Report cover image

Australia and New Zealand Endotoxin Testing Market Report and Forecast 2024-2032

Publisher Expert Market Research
Published Feb 12, 2024
Length 120 Pages
SKU # EMAR18558301

Description

Australia and New Zealand Endotoxin Testing Market Report and Forecast 2024-2032


Australia and New Zealand Endotoxin Testing Market Report and Forecast 2024-2032

Australia and New Zealand Endotoxin Testing Market Outlook

The Australia and New Zealand endotoxin testing market size is anticipated to grow at a CAGR of 9.5% during the forecast period of 2024-2032, driven by the increase in development of innovative, rapid, and sensitive testing methods.

Endotoxin Testing: Introduction

Endotoxin testing is a critical quality control process in pharmaceutical and medical device manufacturing, ensuring products are free from endotoxins, toxic substances released by certain bacteria. The presence of endotoxins can lead to severe reactions such as fever, septic shock, and other complications. The most common method for endotoxin testing is the Limulus Amebocyte Lysate (LAL) test, which utilizes the blood cells of horseshoe crabs to detect endotoxins with high sensitivity and specificity.

Key Trends in the Australia and New Zealand Endotoxin Testing Market

Stringent regulations by healthcare authorities worldwide to ensure drug safety and efficacy, mandating rigorous endotoxin testing. Development of innovative, rapid, and sensitive testing methods to enhance accuracy and reduce turnaround time.

Increasing adoption of automated systems for endotoxin testing, improving efficiency and reproducibility while reducing human error. Growth in the biopharmaceutical sector leads to an increased need for endotoxin testing of biologically derived products, including vaccines and cell therapies.

Heightened focus on drug safety due to global health challenges, such as the COVID-19 pandemic, amplifying the importance of rigorous contamination control.

Efforts to find sustainable alternatives to the traditional LAL test, addressing the conservation concerns related to horseshoe crab harvesting.

Australia and New Zealand Endotoxin Testing Market Segmentation

Market Breakup by Product and Services
  • Endotoxin Detection Kits and Reagents
  • Instruments, Systems, and Software
  • Endotoxin Testing Services
  • Consumables and Accessories
Market Breakup by Test Type
  • Limulus Amoebocyte Lysate (LAL) Test
  • Monocyte Activation Test (MAT)
  • Rabbit Pyrogen Test and Recombinant C (RFC) Assay
Market Breakup by Distribution Channel
  • Pharmacies
  • Online Channel
  • Hypermarkets
Market Breakup by Method
  • Gel Clot Endotoxin Test
  • Chromogenic Endotoxin Test
  • Turbidimetric Endotoxin Test
Market Breakup by Mode of Purchase
  • Large Group
  • Mid and Small Group
  • Individual
Market Breakup by Applications
  • Pharmaceutical Manufacturing
  • Medical Device Manufacturing
  • Raw Materials Production
  • Packaging Manufacture
Market Breakup by End User
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Contract Research Organization (CRO)
  • Contract Manufacturing Organization (CMO)
  • Academic Research Institute and Others
Market Breakup by Country
  • Australia
  • New Zealand
Australia and New Zealand Endotoxin Testing Market Overview

In Australia, the endotoxin testing market is characterized by stringent regulatory standards and a robust biotechnology sector. Strong emphasis on meeting the Therapeutic Goods Administration (TGA) guidelines for product safety, driving the demand for rigorous endotoxin testing. Adoption of advanced testing technologies and automation to increase efficiency and accuracy in endotoxin detection. Expansion of the pharmaceutical and biotechnology sectors, increasing the need for quality control measures including endotoxin testing. Increasing awareness about product safety among manufacturers and consumers, leading to a proactive approach in quality assurance practices.

In New Zealand, the market for endotoxin testing reflects the country's commitment to high-quality healthcare products. High healthcare standards driving the need for strict quality control in pharmaceuticals and medical devices, including endotoxin testing.\ Significant investment in research and development within the biotech sector, necessitating reliable endotoxin testing to ensure product safety and efficacy. Collaboration between academic institutions, research labs, and the biotech industry, fostering advancements in testing methods and technologies. A growing trend towards adopting sustainable and ethical practices in testing, including alternatives to traditional methods that reduce reliance on animal-derived substances like LAL.

Australia and New Zealand Endotoxin Testing Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
  • Viatris Inc.
  • Eurofins Scientific
  • Thermo Fisher Scientific
  • Pall Corporation.
  • Lonza Group AG
  • Charles River Laboratories
  • Merck KGaASteris Inc.
  • Société Générale de Surveillance SA
  • Sartorius AG
  • GenScript
  • Accugen Labs
  • Sigma-Aldrich
  • Nelson Laboratories and Biosynthesis
  • Pacific BioLabs
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

*Please Note:* The report will take 7 business days to complete, after order confirmation.

Table of Contents

120 Pages
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Australia and New Zealand Endotoxin Testing Market Overview
3.1 Australia and New Zealand Endotoxin Testing Market Historical Value (2017-2023)
3.2 Australia and New Zealand Endotoxin Testing Market Forecast Value (2024-2032)
4 Australia and New Zealand Endotoxin Testing Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Australia and New Zealand Endotoxin Testing Market Segmentation
5.1 Australia and New Zealand Endotoxin Testing Market by Product & Services
5.1.1 Market Overview
5.1.2 Endotoxin Detection Kits & Reagents
5.1.3 Instruments, Systems, and Software
5.1.4 Endotoxin Testing Services
5.1.5 Consumables & Accessories
5.2 Australia and New Zealand Endotoxin Testing Market by Test Type
5.2.1 Market Overview
5.2.2 Limulus Amoebocyte Lysate (LAL) Test
5.2.3 Monocyte Activation Test (MAT)
5.2.4 Rabbit Pyrogen Test and Recombinant C (RFC) Assay
5.3 Australia and New Zealand Endotoxin Testing Market by Distribution Channel
5.3.1 Market Overview
5.3.2 Pharmacies
5.3.3 Online Channel
5.3.4 Hypermarkets
5.4 Australia and New Zealand Endotoxin Testing Market by Method
5.4.1 Market Overview
5.4.2 Gel Clot Endotoxin Test
5.4.3 Chromogenic Endotoxin Test
5.4.4 Turbidimetric Endotoxin Test
5.5 Australia and New Zealand Endotoxin Testing Market by Mode of Purchase
5.5.1 Market Overview
5.5.2 Large Group
5.5.3 Mid and Small Group
5.5.4 Individual
5.6 Australia and New Zealand Endotoxin Testing Market by Applications
5.6.1 Market Overview
5.6.2 Pharmaceutical Manufacturing
5.6.3 Medical Device Manufacturing
5.6.4 Raw Materials Production
5.6.5 Packaging Manufacture
5.7 Australia and New Zealand Endotoxin Testing Market by End User
5.7.1 Market Overview
5.7.2 Pharmaceutical Companies
5.7.3 Biotechnology Companies
5.7.4 Medical Device Companies
5.7.5 Contract Research Organization (CRO)
5.7.6 Contract Manufacturing Organization (CMO)
5.7.7 Academic Research Institute and Others
5.8 Australia and New Zealand Endotoxin Testing Market by Country
5.8.1 Market Overview
5.8.2 Australia
5.8.3 New Zealand
6 Patent Analysis
6.1 Analysis by Type of Patent
6.2 Analysis by Publication year
6.3 Analysis by Issuing Authority
6.4 Analysis by Patent Age
6.5 Analysis by CPC Analysis
6.6 Analysis by Patent Valuation
6.7 Analysis by Key Players
7 Grants Analysis
7.1 Analysis by year
7.2 Analysis by Amount Awarded
7.3 Analysis by Issuing Authority
7.4 Analysis by Grant Application
7.5 Analysis by Funding Institute
7.6 Analysis by NIH Departments
7.7 Analysis by Recipient Organization
8 Funding Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
8.6 Analysis by Geography
9 Partnership and Collaborations Analysis
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Partnership
9.3 Analysis by Leading Players
9.4 Analysis by Geography
10 Regulatory Framework
10.1 Regulatory Overview
11 Supplier Landscape
11.1 Viatris Inc.
11.1.1 Financial Analysis
11.1.2 Product Portfolio
11.1.3 Demographic Reach and Achievements
11.1.4 Mergers and Acquisitions
11.1.5 Certifications
11.2 Eurofins Scientific
11.2.1 Financial Analysis
11.2.2 Product Portfolio
11.2.3 Demographic Reach and Achievements
11.2.4 Mergers and Acquisitions
11.2.5 Certifications
11.3 Thermo Fisher Scientific
11.3.1 Financial Analysis
11.3.2 Product Portfolio
11.3.3 Demographic Reach and Achievements
11.3.4 Mergers and Acquisitions
11.3.5 Certifications
11.4 Pall Corporation.
11.4.1 Financial Analysis
11.4.2 Financial Portfolio
11.4.3 Demographic Reach and Achievements
11.4.4 Mergers and Acquisitions
11.4.5 Certifications
11.5 Lonza Group AG
11.5.1 Financial Analysis
11.5.2 Product Portfolio
11.5.3 Demographic Reach and Achievements
11.5.4 Mergers and Acquisitions
11.5.5 Certifications
11.6 Charles River Laboratories
11.6.1 Financial Analysis
11.6.2 Product Portfolio
11.6.3 Demographic Reach and Achievements
11.6.4 Mergers and Acquisitions
11.6.5 Certifications
11.7 Merck KGaA
11.7.1 Financial Analysis
11.7.2 Product Portfolio
11.7.3 Demographic Reach and Achievements
11.7.4 Mergers and Acquisitions
11.7.5 Certifications
11.8 Steris Inc.
11.8.1 Financial Analysis
11.8.2 Product Portfolio
11.8.3 Demographic Reach and Achievements
11.8.4 Mergers and Acquisitions
11.8.5 Certifications
11.9 Société Générale de Surveillance SA
11.9.1 Financial Analysis
11.9.2 Product Portfolio
11.9.3 Demographic Reach and Achievements
11.9.4 Mergers and Acquisitions
11.9.5 Certifications
11.10 Sartorius AG
11.10.1 Financial Analysis
11.10.2 Product Portfolio
11.10.3 Demographic Reach and Achievements
11.10.4 Mergers and Acquisitions
11.10.5 Certifications
11.11 GenScript
11.11.1 Financial Analysis
11.11.2 Product Portfolio
11.11.3 Demographic Reach and Achievements
11.11.4 Mergers and Acquisitions
11.11.5 Certifications
11.12 Accugen Labs
11.12.1 Financial Analysis
11.12.2 Product Portfolio
11.12.3 Demographic Reach and Achievements
11.12.4 Mergers and Acquisitions
11.12.5 Certifications
11.13 Sigma-Aldrich
11.13.1 Financial Analysis
11.13.2 Product Portfolio
11.13.3 Demographic Reach and Achievements
11.13.4 Mergers and Acquisitions
11.13.5 Certifications
11.14 Nelson Laboratories and Biosynthesis
11.14.1 Financial Analysis
11.14.2 Product Portfolio
11.14.3 Demographic Reach and Achievements
11.14.4 Mergers and Acquisitions
11.14.5 Certifications
11.15 Pacific BioLabs
11.15.1 Financial Analysis
11.15.2 Product Portfolio
11.15.3 Demographic Reach and Achievements
11.15.4 Mergers and Acquisitions
11.15.5 Certifications
12 Australia and New Zealand Endotoxin Testing Market - Distribution Model (Additional Insight)
12.1 Overview
12.2 Potential Distributors
12.3 Key Parameters for Distribution Partner Assessment
13 Key Opinion Leaders (KOL) Insights (Additional Insight)
14 Company Competitiveness Analysis (Additional Insight)
14.1 Very Small Companies
14.2 Small Companies
14.3 Mid-Sized Companies
14.4 Large Companies
14.5 Very Large Companies
15 Payment Methods (Additional Insight)
15.1 Government Funded
15.2 Private Insurance
15.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us